Department of Biology, Stanford University, Stanford, CA 94305, USA.
SRI International, Menlo Park, CA 94025, USA.
Mol Cell. 2018 May 3;70(3):516-530.e6. doi: 10.1016/j.molcel.2018.03.026. Epub 2018 Apr 26.
Glycoproteins engaged in unproductive folding in the ER are marked for degradation by a signal generated by progressive demannosylation of substrate N-glycans that is decoded by ER lectins, but how the two lectins, OS9 and XTP3B, contribute to non-glycosylated protein triage is unknown. We generated cell lines with homozygous deletions of both lectins individually and in combination. We found that OS9 and XTP3B redundantly promote glycoprotein degradation and stabilize the SEL1L/HRD1 dislocon complex, that XTP3B profoundly inhibits the degradation of non-glycosylated proteins, and that OS9 antagonizes this inhibition. The relative expression of OS9 and XTP3B and the distribution of glycan and non-glycan degrons within the same protein contribute to the fidelity and processivity of glycoprotein triage and, therefore, determine the fates of newly synthesized proteins in the early secretory pathway.
糖蛋白在 ER 中进行无效益折叠时,会被底物 N-聚糖逐渐去甘露糖化产生的信号标记进行降解,该信号由 ER 凝集素解码,但两种凝集素 OS9 和 XTP3B 如何促进非糖基化蛋白分拣尚不清楚。我们生成了单独和组合缺失这两种凝集素的细胞系。我们发现 OS9 和 XTP3B 可冗余促进糖蛋白降解,并稳定 SEL1L/HRD1 脱位复合物,XTP3B 可深度抑制非糖基化蛋白的降解,而 OS9 拮抗这种抑制。OS9 和 XTP3B 的相对表达水平以及同一蛋白内糖肽和非糖肽降解基序的分布,有助于糖蛋白分拣的保真度和连续性,从而决定新合成蛋白质在早期分泌途径中的命运。